55390-0375 Octreotide Acetate - CanMED: NDC

Return Home

Home

SEER Data & Software

Observational Research in Oncology Toolbox

Product Information

CanMED: NDC

Product NDC:

55390-0375

Brand Name:

Octreotide Acetate

Generic Name:

Octreotide Acetate

Dosage Form Name:

Injection

Administration Route:

Substances:

Packages:

Code: 55390-0375-10

Description:

Effective Date: March 9, 2009

Discontinued: April 30, 2013

SEER*Rx Category:

Hormonal Therapy

Major Class:

Somatostatin Analog

Minor Class:

Orphan Drug Designation:

Yes

Status:

No Longer Used